Results: We found a novel germline PHD2 (EGLN1) gene variant, c.153G>A, p.W51*, in a patient affected by metastatic Pheo and chronic myeloid leukemia (CML) in the absence of polycythemia. This evidence concerns the gene EGLN1 and chronic myelogenous leukemia, BCR-ABL1 positive.